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Summary Two cases of gestational choriocarcinoma have been examined for the expression of HLA and trophoblast antigens using the indirect immunoperoxidase technique on frozen tissue sections. Approximately
40 -70% of tumour cells express MHC Class I antigen as detected by a panel of antibodies to monomorphic,
or framework, MHC Class I antigenic determinants. Evidence in one case suggests that most of these cells
may not express the paternal, polymorphic HLA antigenic determinants but that a small subpopulation do
carry the fully antigenically active molecule. These latter may give rise to patient anti-paternal HLA
antibodies. Class II (HLA DR or DC) antigens are expressed by none, or very few, tumour cells.
Gestational choriocarcinoma is a tumour of unique
immunological interest. It derives from placental
trophoblast and is thereby composed of a cell type
which is not present in the normal non-pregnant
adult and which carries a foreign, paternal
genotype. It may therefore express at its surface
both trophoblast-specific antigens and polymorphic
antigen systems such as HLA.
Evidence for both cellular (Elston, 1969) and
humoral (Lawler et al., 1976, and Shaw et al., 1979)
host antitumour immune responses has been
obtained but direct examination of antigens on the
tumour cell surface has been limited by lack of
available material. Several choriocarcinoma cell
lines have now been established and Class I
antigens have been reported to be absent from the
cell surface of the JaR and Z cell lines (Jones &
Bodmer, 1980), but extracts of JaR cells contain
low levels of the Class I light chain, fl2-micro-
globulin (Trowsdale et al., 1980). Similar extracts of
the BeWo cell line contain both Class I heavy and
light chains. A specific lack of fl2-microglobulin
synthesis has been demonstrated in GCH1 and
GCH2 choriocarcinoma cell lines and, in GCHI,
this has been coupled with the absence of the
relevant messenger RNA (Tanaka et al., 1981).
Manipulation and growth of these cells in vitro may
select certain populations or induce alterations in
the control of gene expression. It is therefore
important to study choriocarcinoma in utero.
In this paper we report examination of two
tumours in utero using the indirect immuno-
peroxidase technique on frozen sections and report
the presence of HLA Class I antigens on a major
subpopulation of tumour cells.
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Patients and methods
Patient I
A 54-year-old woman, gravida 7, para 4, was
admitted to hospital in February 1983 with massive
genital bleeding. Her last pregnancy occurred in
1977 and was a hydatidiform mole of the complete
type. Hysterectomy revealed a uterine tumour
diagnosed histologically as choriocarcinoma and in
the absence of any teratomatous element. Urinary
hCG at the time ofoperation was 102,400IU1-1.
Patient 2
A 52-year-old woman, gravida 5, para 2, whose
previous pregnancy was therapeutically aborted in
1980, presented in January 1984 when she had a
urinary hCG of 128,000iu1-1. Operation and
subsequent histopathology gave a diagnosis of
choriocarcinoma.
Small blocks of tissue were taken at the time of
operation and frozen either in a -700 deep freeze
(patient 1) or directly in liquid nitrogen. Frozen
sections (5-8pum) were cut, the sections air-dried,
fixed in acetone for 10min, air-dried further and
then wrapped individually in aluminium foil so as
to seal them.
Some of these sections were then sent at ambient
temperature from Niigata, Japan, to Bristol, UK,
where they were stored at -200. Sections were
stained with the monoclonal antibodies listed in
Table I using the indirect immunoperoxidase tech-
nique according to previously published procedures
(Sunderland et al., 1981).
All antibodies were used at a predetermined,
saturating dilution. The level of background
staining on each cell type was established with the
MA 2.1 antibody which did not react with uterus or
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Table I Monoclonal antibodies used in the study
Monoclonal antibody Specificity Reference Preparation
W6/32 Class I (HLA-A,B,C) heavy chain, monomorphic
determinanta Barnstaple et al. (1978) Ascites
PA 2.6 Class I (HLA-A,B,C) heavy chain, monomorphic
determinant Brodsky & Parham, (1982) Immunoglobulin
BB 7.7 Class I (HLA-A,B,C) intact molecule only,
monomorphic determinant Brodsky & Parham, (1982) Immunoglobulin
BBM 1 P2 microglobulin, Class I antigen light chain,
monomorphic determinant Brodsky & Parham, (1982) Immunoglobulin
MA 2.1 Class I HLA A2 and B17 only, polymorphic
determinant McMichael et al., (1980) Ascites
ME 1 Class I HLA B7, B22 and B27 only, polymorphic
determinant Eliss et al., (1982) Ascites
NFK 1 Class II (HLA-DR) antigens, monomorphic
determinantb Fuggle et al. (1983) Ascites
Anti Leu 10 Class II (HLA-DC) antigens, monomorphic
determinant unpublishedc Immunoglobulin
F 10-89-4 Leucocyte common antigen Dalchau et al. (1980) Immunoglobulin
Anti Leu M3 Monocyte/macrophage antigen Dimitriu-Bona et al. (1983) Immunoglobulin
TROMA 1 Specialised subgroup of intermediate filaments Kemler et al. Tissue cilture
supernatant
NDOG1 Villous syncytiotrophoblast plasma membrane,
some non-villous trophoblast, unreactive with most
adult tissues, including liver, kidney, heart, brain,
colon, pancreas and pregnant uterus Sunderland et al. (1981) Tissue culture
supernatant
NDOG2 Placental alkaline phosphatase Sunderland et al. (1984b) Tissue culture
supernatant
aThe term "monomorphic" means that the determinant recognised is common to all HLA antigens of this designation.
"The reactivity of this monoclonal antibody with the HLA DC and SB Class II locus products has not yet been determined.
cUnpublished data and antibody available from Becton-Dickinson.
tumour in either patient. Background staining was
minimal in Patient 1 but a low level of diffuse
activity from blood was present close to the site of
tumour implantation in Patient 2.
To control for any selective loss of antigenicity
during transport, sections from the same blocks of
tissue were stained in Niigata using the W6/32
antibody to Class 1 (HLA A,B,C) antigens, a similar
HLA-DR antibody (Cappel Co. USA), NDOG2
and TROMA 1 by the avidin-biotin technique.
Identical results were obtained in Japan and in
Bristol.
Results
Frozen sections of choriocarcinoma tissue were
stained with the panel of monoclonal antibodies
listed in Table I using the indirect
immunoperoxidase technique.
The antibody W6/32 detects a monomorphic
determinant of Class I (HLA A,B,C) antigen
molecules (i.e. it detects all molecules of this class).
The antibody was found to stain a major
population (40-70%) of choriocarcinoma cells in
both tumours examined. The negative tumour cell
population included some prominent groups of
small cytotrophoblasts and some large syncytial
giant cells. The staining pattern is illustrated in
Figure la. Positively stained cells typically showed
an outer ring of reactivity at the plasma membrane
with a lesser reaction in the cytoplasm. Three other
antibodies to monomorphic determinants of MHC
Class I antigens gave identical staining patterns as
judged by comparison of serial sections. These
included antibodies recognising determinants on the
heavy chain (W6/32, PA 2.6), the fJ2-microglobulin
light chain (BBM 1) and determinants generated by
combination of the two polypeptide chains of the
Class I molecule (BB 7.7) (Brodsky & Parham,
1982).
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determinant of the Class I molecule and specifically
detects the HLA B7, B22 and B27 specificities.
Conventional HLA typing of Patient 1 showed her
to carry HLA A24/A31, B7/BW55. Figure lb
demonstrated a positive reaction of the MEl
antibody with the patient's uterine tissue as
expected from her possession of HLA B7. In
contrast the vast majority of tumour tissue did not
react with ME1 (compare Figure lb with la). Such
unreactivity might be due to the fully allogenic
status of this molar-derived tumour whereby it
carries foreign, paternal HLA antigens. The
patient's husband, however, typed as HLA
A24/A26, B7/blank. The B locus blank was noted as
possibly BW60 or BW48, but the probability
remained that the husband was homozygous for
HLA B7 and therefore that the tumour tissue was
of the correct genotype for ME1 reactivity. Small
foci of MEl reactivity were, however, apparent in
some areas of tumours. These cells occurred in
groups and were of variable staining intensity
(Figure 2), making up less than 10% of the total
tumour cell population. They were of typical
tumour cell morphology and were found amongst
populations that were uniformly positive for the
trophoblast marker, TROMA 1 on serial sections.
The MA 2.1 antibody, specific for HLA A2 and
B17, reacted with neither host nor tumour tissue in
Patient 1. Patient 2 was HLA-typed as
A10(A26)/AW33, B35/BW60 or BW61 and her
husband as A2/A30 or A31, BW57/BW48. Neither
MEl nor MA2.1 were reactive with either host or
tumour tissue in this patient.
MHC Class I antigens were absent from the vast
majority of tumour cells (Figure 3). The small
number of scattered DR positive cells seen within
the tumour tissue may derive from the bank of such
DR positive cells present in the uterine tissue
immediately adjacent to the tumour implantation
site (Figure 3). Very similar patterns of reactivity
were found in and around such implantation sites
with NFK-1, antiLeu 10, antiLeu M3 and FID-89-4
suggesting that the majority of these cells may be
DR. DC positive macrophages.
Further heterogeneity of the tumour cells was
demonstrated with monoclonal anti-trophoblast
antibodies. Whilst TROMA 1 stained 90-100% of
tumour cells in both patients, the antibodies
NDOG1 and NDOG2 showed a considerable
variability. In patient 1, NDOG1 reacted with
- 50% of tumour cells and was conspicuous on
groups of cells which did not express Class 1
antigen as assessed on serial sections. In patient 2
NDOG1 reacted with >80% of tumour cells and
stained cells showed no obvious relation to Class 1
antigen expression. The antibody, NDOG2, which
detects placental alkaline phosphatase, was entirely
negative in patient 1, but detected a small group of
large tumour cells in patient 2 which comprised
<10% of the total.
Discussion
Two major populations of choriocarcinoma cells
have been distinguished on the basis of the
expression of MHC Class I antigen monomorphic
determinants (Figure la). Such antigens can also be
detected on major subpopulations of proliferating
extra-villous trophoblast in both the early human
placenta and hydatidiform mole (Sunderland et al.,
1981; 1984). It is from such proliferating extra-
villous trophoblast that choriocarcinoma is detected
similarly by antibodies recognising heavy chain,
light chain or only the intact molecule suggesting
that a balanced, co-ordinated expression of Class I
polypeptide chains predominates in vivo. In
contrast, JaR choriocarcinoma cells in culture have
been shown to express fi2-microglobulin in the
absence of Class I heavy chain (Trowsdale et al.,
1980). In these respects the choriocarcinoma antigen
is similar to that of the normal lymphocyte.
Recent studies of normal placental extra-villous
trophoblast by Redman et al., (1984) have
demonstrated that MHC Class I antigens are
expressed by trophoblast in a manner whereby only
monomorphic but not polymorphic determinants
are detectable and Redman has suggested that
trophoblast MHC Class I antigen might be
biochemically distinct from the lymphocyte antigen.
Similar data have also been obtained for the extra-
villous trophoblast of hydatidiform mole
(Sunderland et al., 1984). Although providing no
definitive data, the present study on chorio-
carcinoma is also consistent with this idea. Thus the
tumour carried by patient 1 derived from a
complete hydatidiform mole and therefore carried
only a paternal genotype (Jacobs et al., 1980). HLA
typing data showed the father to be probably
homozygous B7 and thereby suggested the tumour
carried the HLA B7 haplotype. This was further
supported by the expression of an MEI-reactive
antigen by a very small population of tumour cells
(Figure 2). It is therefore possible that the lack of
MEI reactivity by the vast majority of the cells
which express MHC Class I monomorphic
determinants (Figure 1) is indicative of a similar
abnormality in choriocarcinoma trophoblast as has
been found in normal and molar extra-villous
trophoblast.
In addition to the two major choriocarcinoma
cell populations distinguished by expression of
MHC Class I monomorphic determinants (Figure
la), we have also detected a very small population812 C.A. SUNDERLAND et al.
Figure 1 Gestational choriocarcinoma from Patient 1 was stained with monoclonal antibodies to Class I (HLA A,B,C) antigens using the indirect immunoperoxidase technique on frozen sections. (a) W6/32 monoclonal antibody stains maternal uterine tissue (U) and a major subpopulation of choriocarcinoma cells. A group of unstained small cytotrophoblast cells is arrowed. (x 60). (b) MEI monoclonal antibody specific for HLA B7, B22 and B27 stains the maternal uterine tissue (U) but not the tumour cells. ( x 60). Nuclei were counterstained with hematoxylin.HLA ANTIGENS ON CHORIOCARCINOMA 813
Figure 2 An area of Patient 1 gestational choriocarcinoma tissue in which some cells appeared to express the
polymorphic Class I antigen determinant detected by MEl monoclonal antibody. A group of intensely
reactive and a group ofmuch more weakly reactive tumour cells are arrowed. ( x 190). Otherwise as Figure 1.
SA~~~~~~~~~~ ; st r1 *> tXr~-^ -
Figure 3 Patient 1 gestational choriocarcinoma stained with NFK-1 monoclonal antibody directed to Class
II (HLA DR antigens). Tumour tissue is predominantly unstained, but aggregates of reactive cells are
apparent in the uterine tissue immediately adjacent to the site of tumour implantation. ( x 75). Otherwise as
Figure 1.814 C.A. SUTHERLAND et al.
(Figure 2) which appears to express polymorphic
determinants. The conclusion, however, rests on the
staining of a very few cells in only one case and
must therefore be offered tentatively at this stage.
Such cells have not been previously reported in
normal or molar pregnancy although we have
observed a few cells of this phenotype in anchoring
villous cytotrophoblast present in a normal 12-16
week placenta obtained by pregnancy hysterectomy
(Sunderland & Stirrat, unpublished data). It may be
that it is this antigenically competent third
population of cells which gives rise to the anti
paternal antigen-specific antibodies characteristic of
choriocarcinoma (Lawler et al., 1976; Shaw et al.,
1979). Indeed since this placental tumour manifests
no foetus, foetal circulation or placental villous
stroma, it is difficult to conceive of any other
immunogenic stimulus.
The heterogeneity of this tumour is well
established by conventional histopathology. The
patterns of staining obtained with the monoclonal
antibodies employed here demonstrates a further
dimension to this heterogeneity. This includes three
populations defined by Class 1 antigen expression,
another on the basis of NDOG1 antibody staining
and a third minor population in terms of placental
alkaline phosphatase expression. The clonal
derivation of these cell populations is suggested by
their tendency to occur in groups (eg Figure la).
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